In the News

UVA emergency room doctors are highlighting the virus’s underappreciated risks and potential drug interactions.

UVAToday

UVA Heath researcher Dr. William A. Petri, who is working on a vaccine for COVID-19, takes heart from history.

UVAToday

UVA found that fluvoxamine may prevent dangerous immune system overreactions, a major threat to COVID-19 patients.

UVAToday

UVA has pioneered an innovative new use for telemedicine in the battle against COVID-19, adapting it to improve patient care, conserve PPE and prevent infections.

UVAToday

The University research community is putting the novel coronavirus and its effects under the microscope.

UVAToday

The online registry is an open to all Virginia residents, healthy or sick, and seeks to provide a fuller picture of COVID-19 in the commonwealth.

UVAToday

New approaches under study at UVA could revolutionize treatment for conditions from Alzheimer’s to epilepsy to brain tumors – and even help repair the devastating damage caused by stroke.

UVAToday

Jim Galloway and Timothy Wilson last week became the fourth and fifth UVA faculty members elected to the National Academy of Sciences for their pathbreaking research.

UVAToday